128 related articles for article (PubMed ID: 2944683)
1. The status of receptors in the management of endometrial cancer.
Richardson GS; MacLaughlin DT
Clin Obstet Gynecol; 1986 Sep; 29(3):628-37. PubMed ID: 2944683
[No Abstract] [Full Text] [Related]
2. [Progesterone receptors in endometrial carcinoma and their response to medroxyprogesterone acetate].
Feng YJ; Zhang XY
Zhonghua Fu Chan Ke Za Zhi; 1989 May; 24(3):153-5, 189. PubMed ID: 2530067
[TBL] [Abstract][Full Text] [Related]
3. [Response of estrogen and progesterone receptors to treatment with large doses of progestogen (depo-provera) in endometrial cancer].
Thurzó L
Zentralbl Gynakol; 1990; 112(17):1111-5. PubMed ID: 2148245
[TBL] [Abstract][Full Text] [Related]
4. Hormone-resistant endometriosis following total abdominal hysterectomy and bilateral salpingo-oophorectomy: correlation with histology and steroid receptor content.
Metzger DA; Lessey BA; Soper JT; McCarty KS; Haney AF
Obstet Gynecol; 1991 Nov; 78(5 Pt 2):946-50. PubMed ID: 1833687
[TBL] [Abstract][Full Text] [Related]
5. [Adjuvant gestagen therapy in stage I endometrial cancer].
Lahousen M; Pickel H
Zentralbl Gynakol; 1988; 110(16):1013-7. PubMed ID: 2973195
[TBL] [Abstract][Full Text] [Related]
6. [Adjuvant hormone therapy in endometrial carcinoma: medroxyprogesterone acetate versus tamoxifen-medroxyprogesterone acetate sequential therapy].
Vavra N; Salzer H; Sevelda P; Breitenecker G; Czerwenka K; Kucera H
Gynakol Rundsch; 1990; 30(3):133-43. PubMed ID: 2147161
[TBL] [Abstract][Full Text] [Related]
7. [Estrogen and progesterone receptors in endometrial carcinoma during high-dose progestogen (Depo-Provera) therapy].
Thurzó L; Sas M; Falkay G
Orv Hetil; 1986 Oct; 127(43):2613-6. PubMed ID: 2947029
[No Abstract] [Full Text] [Related]
8. [Current status of drug treatment of endometrial carcinoma].
Schulz KD; Kaiser R
Gynakologe; 1983 Jun; 16(2):114-8. PubMed ID: 6193040
[No Abstract] [Full Text] [Related]
9. [Gestagens and uterine neoplasms].
Ravina JH
Nouv Presse Med; 1973 Jun; 2(24):1665-6. PubMed ID: 4352276
[No Abstract] [Full Text] [Related]
10. Steroid hormone receptors and response to high-dose medroxyprogesterone acetate in advanced breast cancer.
Nomura Y; Tashiro H; Hisamatsu K; Shinozuka K
Anticancer Res; 1988; 8(4):647-51. PubMed ID: 2972248
[TBL] [Abstract][Full Text] [Related]
11. [Growth of endometrial cancer and hormone].
Kanoh H; Hosono T; Matsui Y; Okudaira Y
Gan To Kagaku Ryoho; 1989 Dec; 16(12):3696-703. PubMed ID: 2531993
[TBL] [Abstract][Full Text] [Related]
12. [Progestins in combined treatment of endometrial cancer].
Voznyĭ EK; Titova VA
Sov Med; 1990; (9):102-7. PubMed ID: 2148437
[No Abstract] [Full Text] [Related]
13. Endometrial hyperplasia: a prospective randomized study of histopathology, tissue steroid receptors and plasma steroids after abrasio, with or without high dose gestagen treatment.
Lindahl B; Alm P; Fernö M; Norgren A
Anticancer Res; 1990; 10(3):725-30. PubMed ID: 2142394
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of in vivo and in vitro responses of endometrial adenocarcinoma to progestins.
Holinka CF; Deligdisch L; Deppe G; Fleming H; Namit C; de la Pena MM; Gurpide E
Adv Exp Med Biol; 1981; 138():365-76. PubMed ID: 6211063
[No Abstract] [Full Text] [Related]
15. Mechanism of antitumoral activity of medroxyprogesterone acetate for endometrial cancer.
Fujimoto J; Fujita H; Hosoda S; Okada H
Nihon Sanka Fujinka Gakkai Zasshi; 1989 Nov; 41(11):1836-40. PubMed ID: 2531782
[TBL] [Abstract][Full Text] [Related]
16. [A case of marked effectiveness using medroxyprogesterone acetate (MPA) in lung metastases of cancer of the uterine body].
Takeda M; Kubo K; Fukushima M; Hirayama J; Sekiguchi M
Gan To Kagaku Ryoho; 1990 Oct; 17(10):2113-7. PubMed ID: 2145808
[TBL] [Abstract][Full Text] [Related]
17. [Clinovir treatment of adenocarcinoma of the uterus with lung metastases].
Stertmann WA; Hocke M; Röttger P
MMW Munch Med Wochenschr; 1983 Jul; 125(29-30):685-6. PubMed ID: 6225946
[No Abstract] [Full Text] [Related]
18. Endolymphatic stromal myosis: surgical and hormonal therapy for extensive venous recurrence.
Montag TW; Manart FD
Gynecol Oncol; 1989 May; 33(2):255-60. PubMed ID: 2539319
[TBL] [Abstract][Full Text] [Related]
19. Endometrial hyperplasia. Clinico-pathological considerations of a prospective randomised study after abrasio only or high-dose gestagen treatment. Results of 2 years follow-up of 292 patients.
Lindahl B; Willén R
Anticancer Res; 1991; 11(1):403-6. PubMed ID: 1826823
[TBL] [Abstract][Full Text] [Related]
20. Hormonal receptors in endometrial neoplasias.
Contreras Ortiz O; Sananes CE
Eur J Gynaecol Oncol; 1988; 9(5):396-8. PubMed ID: 2975993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
